Results 91 to 100 of about 54,621 (145)
Proposed strategy after complete LAMN (low-grade appendiceal mucinous neoplasm) resection by different RENAPE units: need for a new consensus? [PDF]
Pleura PeritoneumMouawad C, Taibi A, Sgarbura O, Djelil D, Marchal F, Sourrouille I, Goere D, Glehen O, Ferron G, Dumont F, Courvoisier Clement T, Brigand C, Amroun KL, Abboud K, Villeneuve L, Pocard M, RENAPE Group. +16 moreeuropepmc +1 more sourceImpact of lymph node staging on survival in presumed early-stage ovarian cancer: a multicentric retrospective study. [PDF]
J Gynecol OncolOuasti S, Alline J, Kerbage Y, Zerbib E, Ouldamer L, Bendifallah S, Huchon C, Lorenzini J, Lavoué V, Raimond E, Costaz H, Dupré PF, Graesslin O, Uzan J, Canlorbe G, Azaïs H, Carcopino X, Touboul C, Mimoun C, Dabi Y. +19 moreeuropepmc +1 more sourceA large French family with TGFBR2 pathogenic variant: illustration of variability. [PDF]
Orphanet J Rare DisEliahou L, Milleron O, Haviari S, Arnoult F, Hanna N, Arnaud P, Toure F, Jadoui S, Mirmiran A, Boileau C, Jondeau G. +10 moreeuropepmc +1 more sourceDyspnea as a marker of prognosis in immunocompromised patients with acute respiratory failure. [PDF]
Ann Intensive CareDemoule A, Decavèle M, Mehta S, Bauer PR, Metaxa V, Pène F, Girault C, Munshi L, Taccone FS, Antonelli M, Barbier F, Barratt-Due A, Burghi G, Canet E, Kouatchet A, Lemiale V, Martin-Loeches I, Mokart D, Moreau AS, Montini L, Pickkers P, Rello J, Schellongowski P, Terzi N, Valkonen M, de Louw AV, Azoulay E, Darmon M, Efraim investigators and the Nine-I study group. +28 moreeuropepmc +1 more sourceClinical and Pathological Features Associated with Chromophobe Renal Cell Carcinoma Recurrence: Analysis from a Nationwide Cohort. [PDF]
Eur Urol Open SciPeyrottes A, Auclin E, Timsit MO, Branger N, Doumerc N, Waeckel T, Bigot P, Surlemont L, Knipper S, Pignot G, Bruyère F, Fontenil A, Parier B, Champy C, Rouprêt M, Patard JJ, Henon F, Fiard G, Guillotreau J, Beauval JB, Michel C, Bernardeau S, Taha F, Mallet R, Panthier F, Guy L, Vignot L, Khene ZE, Bernhard JC, Méjean A, Audenet F. +30 moreeuropepmc +1 more sourceStudy protocol and statistical plan for the ICRAKI trial: Intermittent haemodialysis versus continuous renal replacement therapy for severe acute kidney injury in critically ill patients. [PDF]
Crit Care ResuscGaudry S, Boubaya M, Louis G, Chaïbi K, Mégarbane B, Bohe J, Desgrouas M, Gele-Decaudin G, Joseph A, de Montmollin E, Camus C, De Prost N, Bailly P, Jaber S, Chudeau N, Lambour A, Robine A, La Combe B, Kimmoun A, Chevrel G, Argaud L, Nicolas J, Thiery G, Faguer S, Jozwiak M, Ricard JD, Contou D, Marzouk M, Chousterman B, Cadiet J, Bureau C, Zaleski ID, Rossignol P, Quenot JP, Queyrat CB, Dreyfuss D. +35 moreeuropepmc +1 more sourceInflammatory disorders in IDH-mutated myeloid neoplasms: Characteristics and response to IDH inhibitors. [PDF]
HemasphereStammler R, Chen P, Debeaupuis O, Zhao LP, Ruyer-Thompson M, Zakine E, Rossignol J, Goldwirt L, Comont T, Heiblig M, Adès L, Sebert M, Allain JS, Campagne J, Couturier MA, Cumin M, Dalmas MC, Denis G, Devloo C, De Voeght A, Drevon L, Duffau P, Georgin-Lavialle S, Gobert D, Kosmider O, Rieux-Laucat F, Abisror N, Lazaro E, Lopez JG, Maria A, Mauhin W, Merindol J, Merlot C, Mirault T, Pascal L, Perrin F, Raffoux E, Rahme R, Roos-Weil D, Terrier B, Thoreau B, Fain O, Fenaux P, Hirsch P, Jachiet V, Hadjadj J, Mékinian A, MINHEMON. +47 moreeuropepmc +1 more source